Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome

Annals of the New York Academy of Sciences
Soo LimHong Kyu Lee

Abstract

The number of individuals with metabolic syndrome is increasing worldwide, constituting a major social problem in many countries. Recently, epidemiological and experimental studies have associated insulin resistance or type 2 diabetes with elevated body burdens of persistent organic pollutants (POPs). It has been proposed that mitochondrial dysfunction plays a key role in this association. Mitochondrial DNA abnormalities are known to cause pancreas beta cell damage, insulin resistance, and diabetes mellitus. Recently, much evidence has emerged showing that environmental toxins, including POPs, affect mitochondrial function and subsequently induce insulin resistance. In this review, we present a novel concept in which metabolic syndrome is the result of mitochondrial dysfunction, which in turn is caused by exposure to POPs. The potential mechanism including POPs for mitochondrial dysfunction on metabolic syndrome is also discussed. We propose that the mitochondrial paradigm for the etiology of metabolic syndrome will facilitate the prevention and treatment of this major health problem.

References

Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·B N AmesT M Hagen
Jun 15, 1999·European Journal of Applied Physiology and Occupational Physiology·H WangE P Brass
Nov 26, 1999·Obesity Research·A TremblayD Richard
Sep 14, 2000·European Journal of Applied Physiology·S LimH K Lee
Nov 28, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J ChevrierA Tremblay
May 10, 2001·The Journal of Clinical Endocrinology and Metabolism·C WeyerP A Tataranni
Feb 8, 2002·American Journal of Physiology. Endocrinology and Metabolism·Pascal ImbeaultDenis R Joanisse
Jul 13, 2002·Lancet·Robert S LindsayJonathan Krakoff
Sep 17, 2002·The American Journal of Cardiology·Kitt F Petersen, Gerald I Shulman
Jan 28, 2003·Lancet·Joachim SprangerAndreas F H Pfeiffer
Mar 1, 2003·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·C PelletierA Tremblay
May 17, 2003·Science·Kitt Falk PetersenGerald I Shulman
Oct 11, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Yuji MatsuzawaIichiro Shimomura
Oct 15, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·R K SempleS O'Rahilly
Oct 18, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Julio S G MontanerMichael V O'Shaughnessy
Oct 16, 2004·Science·Umut OzcanGökhan S Hotamisligil
Jan 22, 2005·Science·Bradford B Lowell, Gerald I Shulman
Feb 5, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Ulrich LaufsGeorg Nickenig
Apr 6, 2005·The Journal of Nutritional Biochemistry·Yun Yong LeeHong Kyu Lee
May 3, 2005·The Journal of Clinical Investigation·Kathryn E Wellen, Gökhan S Hotamisligil
May 4, 2005·Cell Biology and Toxicology·B SalazardJ-L Bergé-Lefranc
Jun 3, 2005·Current Diabetes Reports·Rebecca Parish, Kitt Falk Petersen
Dec 13, 2005·Neurochemical Research·Peter KlivenyiLaszlo Vecsei

❮ Previous
Next ❯

Citations

Jul 8, 2011·Human Genetics·Germaine EscamesDarío Acuña-Castroviejo
Apr 28, 2012·Diabetology & Metabolic Syndrome·Shi-Sheng ZhouJi-Min Cao
Nov 12, 2013·International Journal of Molecular Sciences·Mario ArcielloClara Balsano
Apr 12, 2013·Oxidative Medicine and Cellular Longevity·Carla LubranoLucio Gnessi
Jul 24, 2013·TheScientificWorldJournal·Deanna M Minich, Jeffrey S Bland
Jan 15, 2014·Diabetes Research and Clinical Practice·Juliana C N ChanJonathan Shaw
Oct 26, 2012·TheScientificWorldJournal·Noori Al-WailiMohammad Javed Ansari
Feb 2, 2013·Canadian Journal of Physiology and Pharmacology·Sean BryanNeelam Khaper
Nov 9, 2011·Translational Research : the Journal of Laboratory and Clinical Medicine·Saba KhanPradyumna K Mishra
Apr 5, 2013·Annals of the New York Academy of Sciences·Ronald C W Ma, Juliana C N Chan
Aug 28, 2015·Environmental Science and Pollution Research International·Raymond Tsz Man Chung
Aug 21, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Nathalie Zucchini-PascalRoger Rahmani
Jun 20, 2013·Toxicology and Applied Pharmacology·Mohammed El Amine BenarbiaYves Malthièry
Dec 3, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Y-M LeeD-H Lee
Mar 17, 2017·Journal of Environmental Science and Health. Part A, Toxic/hazardous Substances & Environmental Engineering·Kwang Sik SuhSuk Chon
Nov 4, 2017·Current Diabetes Reports·Chunxue YangArthur C K Chung
Apr 8, 2015·Drug Development Research·Kodeeswaran ParameshwaranCarl A Pinkert
May 21, 2015·The Journal of Clinical Endocrinology and Metabolism·Teresa M Attina, Leonardo Trasande
Feb 4, 2014·Endocrine Reviews·Duk-Hee LeeLaura N Vandenberg
Mar 29, 2018·Endocrinology and Metabolism·Soo Heon Kwak, Kyong Soo Park
Oct 17, 2017·Environmental Science and Pollution Research International·Jun-Tae KimSung-Deuk Choi
Feb 23, 2019·Frontiers in Endocrinology·Christopher D Kassotis, Heather M Stapleton
Feb 14, 2019·International Journal of Health Geographics·Mohan ThanikachalamSadagopan Thanikachalam
Jan 3, 2019·Annals of Pediatric Endocrinology & Metabolism·Chunxue YangArthur C K Chung
Dec 4, 2010·Journal of Environmental Monitoring : JEM·Charles Jay EverettMarty Player
Mar 28, 2019·Frontiers in Endocrinology·Sarah E Elmore, Michele A La Merrill
Jun 3, 2021·International Journal of Molecular Sciences·Raquel CanoValmore Bermúdez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.